INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2014
|
Net Assets |
£224m |
|
Net Assets per share |
447p |
|
Share price |
386p |
|
Total value of unquoted investments |
£17m |
|
Total number of portfolio companies |
83 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
8.7 |
|
Gilead |
8.4 |
|
Regeneron |
7.4 |
|
Alexion |
5.4 |
|
Amgen |
4.8 |
|
Biogen-Idec |
4.0 |
|
Illumina |
3.8 |
|
Chimerix |
3.5 |
|
Biomarin |
3.2 |
|
Actelion |
2.9 |
|
|
----------- |
|
Total |
52.1 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
57 |
|
Turning Profitable 2015 |
7 |
|
Unprofitable |
36 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
93 |
|
Europe & UK |
7 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
88 |
|
Unquoted |
12 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
27 NOVEMBER 2014